I recently came across this report highlighting the results of a goserelin implant for breast cancer patients as an alternative to traditional chemotherapy. Chemotherapy is well-known to be an incredibly user-unfriendly process. From requiring regular cocktails of many different drugs to unwanted but necessary side effects to the overall cost of treatment, there appears to be a large range for improvement and innovation in the ways patients conquer cancer.
Considering Hera Health Solutions’ development of biodegradable drug delivery implants, I believe that there may be room for a potentially groundbreaking application of their technology in this field.
Comments